Legato Capital Management’s Medpace MEDP Stock Holding History

Legato Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$624K	Buy	1,300 +543	+72%	+$278K	0.06%	477
2025 Q4	$425K	Sell	757 -327	-30%	-$186K	0.04%	613
2025 Q3	$557K	Sell	1,084 -26	-2%	-$11.4K	0.06%	431
2025 Q2	$348K	Hold	1,110	–	–	0.04%	484
2025 Q1	$338K	Sell	1,110 -115	-9%	-$38.7K	0.05%	473
2024 Q4	$407K	Hold	1,225	–	–	0.05%	469
2024 Q3	$409K	Sell	1,225 -3,463	-74%	-$1.32M	0.05%	469
2024 Q2	$1.93M	Sell	4,688 -1,922	-29%	-$761K	0.26%	123
2024 Q1	$2.67M	Sell	6,610 -1,299	-16%	-$457K	0.32%	85
2023 Q4	$2.42M	Sell	7,909 -474	-6%	-$128K	0.32%	77
2023 Q3	$2.03M	Buy	8,383 +969	+13%	+$248K	0.29%	92
2023 Q2	$1.78M	Hold	7,414	–	–	0.24%	132
2023 Q1	$1.39M	Hold	7,414	–	–	0.25%	125
2022 Q4	$1.57M	Buy	+7,414	New	+$1.48M	0.3%	99

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Legato Capital Management's MEDP Position: Q1 2026 in Review

Legato Capital Management increased its Medpace (MEDP) stake by 72% in Q1 2026, buying an estimated $278K and bringing the position to 1,300 shares worth $624K. The position accounts for 0.06% of the portfolio, ranked #477.

Legato Capital Management first reported a position in MEDP in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.67M in Q1 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Legato Capital Management held 1,300 shares of Medpace worth $624K as of Q1 2026.
Legato Capital Management bought 543 Medpace shares in Q1 2026, an estimated $278K.
Medpace made up 0.06% of Legato Capital Management's portfolio in Q1 2026, its #477 holding.
Legato Capital Management first reported a position in Medpace in Q4 2022 and has held it in 14 quarters since.
Legato Capital Management's Medpace position peaked at $2.67M in Q1 2024.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.